HHS gives $316,000 for University of Alabama study on ‘vaginal health for transgender men on testosterone’

Testosterone therapy in biological women has been found to suppress ovarian estrogen production, creating a hypoestrogenic state that can thin vaginal tissue and cause atrophic changes similar to those experienced after menopause.